About
Lucid Diagnostics Inc (NASDAQ:LUCD) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
Mar 26 2026
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 12 2026
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026
Jan 21 2026
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®
Dec 9 2025
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection
Recent Videos

🔥🔥 The Voice. The Vision. The Story. | Dr. Sunitha Lingareddy | Podcast Promo 🔥 #LucidDiagnostics
Apr 15, 2026

Lucid Diagnostics Q4 2025 Earnings Call | Revenue Rises to $1.5M on Record EsoGuard Test Volumes
Mar 27, 2026

Lucid Diagnostics (LUCD|$165.2M) - 2025 Q4 & Full Year Earnings Analysis
Mar 26, 2026

PAVmed Stock Surge: Huge VA Contract Win and Short Squeeze Potential |
Jan 22, 2026
Financials
Revenue
$4.71 M
Market Cap
$194.21 M
EPS
-0.69
Google Übersetzer